BNTC
Benitec Biopharma·NASDAQ
--
--(--)
--
--(--)
BNTC fundamentals
Benitec Biopharma (BNTC) released its earnings on May 14, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.24 (YoY +85.37%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.24
+85.37%
Report date
May 14, 2025
EPS
Actual | -10.54 | -10.03 | -6.8 | -10.54 | -7.99 | -3.4 | -2.72 | -0.01 | -2.76 | -2.64 | -1.64 | 1.04 | -0.48 | -0.33 | -0.24 | |||||
Forecast | -12.75 | -14.45 | -15.81 | -7.48 | -4.76 | -3.145 | -1.87 | -3.4 | -3.23 | -0.51 | -0.39 | -0.78 | -0.4875 | -0.55 | -0.7757 | -0.3483 | ||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +9.09% | -121.43% | -154.05% | -81.82% | +20.00% | +99.69% | -441.18% | -576.92% | -110.26% | +313.33% | +12.73% | +57.46% | +31.09% |
Revenue
Actual | -- | -- | -- | -- | -- | 0 | 25.00K | 48.00K | 0 | 0 | 14.00K | 54.00K | 15.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | -- | 35.00K | 5.00K | 5.00K | -- | -- | 0 | 0 | 9.50K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What is the revenue and EPS growth rate for Benitec Biopharma year over year?What guidance did Benitec Biopharma's management provide for the next earnings period?What were the key takeaways from Benitec Biopharma's earnings call?What is Benitec Biopharma's latest dividend and current dividend yield?What is the market's earnings forecast for Benitec Biopharma next quarter?Did Benitec Biopharma beat or miss consensus estimates last quarter?What is Benitec Biopharma's gross profit margin?What does Benitec Biopharma do and what are its main business segments?
